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Proopiomelanocortin peptides such as a-melano-
cyte-stimulating hormone and adrenocorticotropin
are expressed in the epidermal and dermal compart-
ment of the skin after noxious stimuli and are recog-
nized as modulators of immune and in¯ammatory
reactions. Human dermal microvascular endothelial
cells mediate leukocyte±endothelial interactions
during cutaneous in¯ammation by the expression of
cellular adhesion molecules and cytokines such as
interleukin-1. This study addresses the hypothesis
that human dermal microvascular endothelial cells
express both proopiomelanocortin and prohormone
convertases, which are required to generate proopio-
melanocortin peptides. Semiquantitative reverse
transcriptase polymerase chain reaction and northern
blot studies revealed a constitutive expression of
proopiomelanocortin mRNA by human dermal
microvascular endothelial cells in vitro that was time-
and concentration-dependently upregulated by inter-
leukin-1b. Furthermore, irradiation of human dermal
microvascular endothelial cells with ultraviolet A1
(30 J per cm2) or ultraviolet B (12.5 mJ per cm2)
enhanced proopiomelanocortin expression as well as
the production and release of the proopiomelano-
cortin peptides adrenocorticotropin and a-melano-
cyte-stimulating hormone. In addition to
proopiomelanocortin, prohormone convertase 1
mRNA expression was detected by reverse transcrip-
tase polymerase chain reaction in unstimulated
human dermal microvascular endothelial cells and
was augmented after exposure to a-melanocyte-
stimulating hormone, interleukin-1b, or irradiation
with ultraviolet. These ®ndings demonstrate that
human dermal microvascular endothelial cells
express proopiomelanocortin and prohormone con-
vertase 1 required for the generation of adrenocorti-
cotropin. Additionally, human dermal microvascular
endothelial cells express mRNA for the prohormone
convertase 2 binding protein 7B2. Taken together
these ®ndings indicate that human dermal micro-
vascular endothelial cells upon stimulation express
both proopiomelanocortin and prohormone conver-
tases required for the generation of a-melanocyte-
stimulating hormone. As proopiomelanocortin
peptides were found to regulate the production of
human dermal microvascular endothelial cell cyto-
kines and adhesion molecules and to have a variety
of anti-in¯ammatory properties these peptides may
signi®cantly contribute to the modulation of skin
in¯ammation. Key words: endothelial cell/melanocyte-
stimulating hormone/prohormone convertase/proopiomela-
nocortin/UV light. J Invest Dermatol 115:1021±1028, 2000
P
roopiomelanocortin (POMC) peptides, originally dis-
covered as pituitary hormones, have been detected in
various tissues including the skin and are expressed by
epidermal and dermal cells such as melanocytes, kerati-
nocytes, or ®broblasts as well as by in¯ammatory cells
including cutaneous monocytes, macrophages, and neutrophils
(reviewed by Luger et al, 1997; Slominski et al, 2000). In these cells,
transcription and release of POMC peptides in vivo and in vitro changes
during the hair cycle (Slominski et al, 1992, 1993a) and is increased
after trauma, infection (Catania et al, 1994, 1998), or exposure to
ultraviolet (UV) light. This may in part be secondary to the release of
interleukin-1 (IL-1), which is capable of enhancing POMC
production (Schauer et al, 1994; Chakraborty et al, 1995, 1996a;
Wintzen et al, 1996). In neuroendocrine tissues, post-translational
processing of an inactive cytoplasmic POMC prohormone generates
up to eight different POMC peptides including a-, b-, g-
melanocyte-stimulating hormone (MSH), adrenocorticotrophic
hormone (ACTH), and b-endorphin. This generation involves
proteolytic cleavage of the POMC precursor protein by prohormone
convertases (PC) 1 and 2, which belong to the subtilisin/kexin-type,
as well as a-amidation or acetylation (Marcinkiewicz et al, 1993;
Seidah et al, 1999). In skin cells, POMC expression can be induced by
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UV light, which has been implicated in cutaneous carcinogenesis and
local as well as systemic immunosuppression (Kripke, 1990;
Shreedhar et al, 1998; Slominski and Pawelek, 1998; Luger et al,
1999). The latter has been attributed to impaired antigen-presenting
functions of Langerhans cells and the induction of anti-in¯ammatory
mediators such as IL-10 and a-MSH or, in some cases, calcitonin
gene-related peptide (Niizeki and Streilein, 1997; Luger et al, 1998;
Scholzen et al, 1999).
Among POMC peptides, a-MSH is regarded as a neurohor-
mone with extensive immunomodulatory capacities (Luger et al,
1998). a-MSH has been demonstrated to regulate proliferation and
differentiation of keratinocytes and melanocytes and to modulate
®broblast and endothelial cell cytokine production in vitro (Lipton
et al, 1997; Luger et al, 1998). It is capable of downregulating the
expression of the costimulatory molecules CD86 and CD40 on
monocytes and peripheral-blood-derived dendritic cells. In addi-
tion, it induces monocyte anti-in¯ammatory cytokines such as IL-
10 in vitro (Bhardwaj et al, 1996, 1997; Becher et al, 1999). In vivo,
a-MSH demonstrates immunosuppressive activities both locally
and systemically, such as the inhibition of murine contact
hypersensitivity and the induction of hapten-speci®c tolerance
(Grabbe et al, 1996; Lipton and Catania, 1997).
POMC peptide effects are exerted by activation of 5 G-protein-
coupled melanocortin receptors (MC-1R±MC-5R) (Cone et al,
1996). Epidermal and dermal cells predominantly express MC-1R,
which exhibits high af®nity for a-MSH and ACTH. Recently,
human dermal microvascular endothelial cells (HDMECs) were
found to express MC-1R. Functionally, MC-1R-expressing
HDMECs responded to stimulation with a-MSH with an
increased production of the C-X-C chemokines IL-8 and
growth-related oncogene a (Hartmeyer et al, 1997; Scholzen et al,
1998a).
The expression of HDMEC cellular adhesion molecules and
cytokines are crucial events that mediate leukocyte±endothelial cell
interaction and transmigration into the extravascular tissue during
skin in¯ammation (Swerlick and Lawley, 1993; Barker, 1995).
These events require the activation of endothelial cells by
proin¯ammatory cytokines such as IL-1 or tumor necrosis factor
a (TNF-a) that are released from epidermal keratinocytes (Luger
and Schwarz, 1995). Endothelial cells are also capable of
synthesizing a repertoire of growth factors, cytokines, and
chemokines. Increased production of these factors can be observed
after exposure of endothelial cells to certain cytokines, neuropep-
tides, or UV light (Goebeler et al, 1997; Mantovani et al, 1997;
Scholzen et al, 1998a; 1998b).
In order to get further insight into the signi®cance of MC-1R
and its ligands for endothelial cell biology we examined the
HDMEC capability for expressing POMC and POMC-processing
enzymes. In this study we demonstrate that HDMECs synthesize
POMC mRNA and release the POMC peptides ACTH and a-
MSH, which can be regulated by IL-1 or UV light.
MATERIALS AND METHODS
Cell culture and reagents HDMECs were isolated from human
foreskins by trypsin treatment and Percoll gradient centrifugation using a
protocol modi®ed from Kubota et al (1988). Brie¯y, neonatal foreskins
were cut into 5 mm stripes, placed in a 100 mm Petri dish, and washed in
phosphate-buffered saline (PBS) containing 0.3% trypsin and 0.2%
ethylenediamine tetraacetic acid at 4°C. To separate dermis and
epidermis, the skin segments were incubated for 18 h with 2.5% trypsin.
Subsequently, epidermis and dermis were separated using sterile forceps.
The dermal segments were placed in a Petri dish containing 5 ml modi®ed
Eagle's medium and microvascular fragments were expressed by
compression of individual fragments of dermis with the side of a scalpel
blade. The microvascular fragments were passed through a 100 mm nylon
mesh and collected. The microvascular segments were layered on a Percoll
(Pharmacia, Uppsala, Sweden) gradient preformed by centrifugation of 35%
Percoll in Hank's balanced salt solution (HBSS) at 30,000g for 10 min. The
gradient was spun at 400g for 15 min at room temperature. The fraction
with a density less than 1.048 g per ml containing endothelial cells was then
plated in 100 mm Primaria Petri dishes (Falcon Plastics, Cockeysville, MD).
Nonattached cells were removed by washing with HBSS. Cells were
grown in endothelial cell basal medium (EBM-Kit MV; PromoCell,
Heidelberg, Germany) supplemented with 10% fetal bovine serum, 0.1 ng
per ml epidermal growth factor, 1.0 ng per ml basic ®broblast growth factor,
and 1.0 mg per ml hydrocortisone without antibiotics (growth medium).
Typically, cells in passages 3±5 were used for experiments. In order to
verify that cultured HDMECs were free of contaminating cells such as
®broblasts HDMEC cultures were characterized by their typical
cobblestone morphology using light microscopy and by ¯ow cytometry
analysis regarding their capacity to express factor-VIII-like antigen.
To analyze POMC or PC expression HDMECs (2 3 106) were grown
in 100 mm Petri dishes for 24 h to 80%±90% con¯uence in growth medium
as described above. Subsequently, the cells were cultured for 15 h or
overnight in medium containing 2% fetal bovine serum only (depletion
medium), and were then treated with a-MSH (Bachem, Heidelberg,
Germany) in various concentrations (10±8±10±12 M) or with IL-1b (0.1±
10.0 ng per ml; Sigma, St. Louis, MO) in fresh depletion medium for 1±
48 h.
UV treatment Endothelial cells (2 3 106) were grown in 100 mm Petri
dishes and depleted as described above. For UV irradiation, the culture
medium was replaced by PBS and cells were irradiated with a bank of four
FS20 ¯uorescent lamps (Westinghouse Electric, Pittsburgh, PA), which
emit most of their energy within the UVB range (280±320 nm) with an
emission peak at 313 nm. The UV output measured at 310 nm using an IL
1700 research radiometer was 8.0 W per m2 at a distance of 28 cm. For
UVA1 treatment, cells were exposed to a UVASUN 5000 irradiation
device (Mutzhas, Munich, Germany) emitting in the range 320±465 nm,
with a maximum at 375 nm. The emission was ®ltered with UVACRYL
(Mutzhas) and UG1 (Schott Glaswerke, Munich, Germany) and consisted
exclusively of wavelengths greater than 340 nm. Cell viability before and
after irradiation was more than 95% as determined by trypan blue exclusion.
After irradiation, the PBS was replaced with fresh medium and cells were
further incubated for the indicated time.
RNA isolation Total RNA was isolated by the acid guanidinium
thiocyanate-phenol-chloroform method (Chomczynski and Sacchi, 1987).
The RNA pellets were washed with 80% ethanol, dried, and dissolved in
diethylpyrocarbonate-treated RNase-free water. To avoid DNA
contamination, total RNA was treated with 10 U RNase-free DNase I
(Boehringer Mannheim, Germany) in a buffer containing 1.5 mM MgCl2,
50 mM KCl, 10 mM Tris-HCl pH 8.3 for 1 h at 37°C.
Semiquantitative reverse transcriptase polymerase chain reaction
(RT-PCR) One microgram RNA was subjected to reverse transcription
using the Promega Reverse Transcription System in a ®nal volume of 20 ml
containing 5 mM MgCl2, 1 3 reverse transcriptase buffer [10 mM Tris-
HCI (pH 8.8 at 25°C), 50 mM KCl, 0.1% Triton X-100], 1 mM of each
dNTP, 1 U per ml rRNasin, 15 U AMV reverse transcriptase, and 0.5 mg
oligo-(dT)15 primer. Tubes were incubated for 60 min at 42°C with a
5 min inactivation of the AMV reverse transcriptase at 95°C, chilled on ice,
and diluted to a ®nal volume of 100 ml w/DEPC-H2O.
PCR conditions allowing reliable comparison of POMC and PC1
expression with b-actin mRNA as housekeeping gene expression in
different samples were established using a protocol modi®ed from Paludan
and Thestruppedersen (1992) by making serial dilutions of template cDNA
at constant cycle numbers for each primer pair to verify that the subsequent
PCR reactions were performed in the linear range of PCR ampli®cation.
Subsequently, cDNA mixtures were diluted to obtain similar amounts of
PCR product speci®c for ampli®ed b-actin and subjected to ampli®cation
of POMC (143 bp) and PC1-speci®c (674 bp), PC2-speci®c (191 bp), or
7B2-speci®c (443 bp) PCR products using the oligonucleotide primer pairs
listed below. For PCR ampli®cation, 50 ml reactions containing appropriate
volumes of diluted cDNA reaction mix, 200 mM dNTP (each), 20±50 pM
of each primer, and the standard buffer supplemented with Taq Polymerase
(2.5 U per reaction, Promega) and 1.5±2.0 mM MgCl2 were used.
Nucleotide sequences for PCR primers and ampli®cation programs were
as follows. b-actin was ampli®ed using the sense primer 1 5¢-CAC-
CTTCTACAATGAGCTGC-3¢ and the antisense primer 1 5¢-TTCAT-
GAGGTAGTCCGTCAG-3¢, or alternatively the b-actin sense primer 2
5¢-ATCTGGCACCACACCTTCTACAATGAGCTGCG-3¢ and the
antisense primer 2 5¢-CGTCATACTCCTGCTTGCTGATCCACATC-
TGC-3¢ (Clontech, LaJolla, CA), and the following ampli®cation program:
1 cycle of 94°C, 10 min; 58°C, 2 min; 72°C, 1 min; followed by 33 cycles
of 94°C, 45 s; 58°C, 45 s; 72°C, 1 min; and a ®nal cycle of 94°C, 45 s;
58°C, 45 s; and 72°C, 10 min. POMC was ampli®ed using the sense primer
5¢-TCAGCCTGCCTGGAAGATGCC-3¢, the antisense primer 5¢-
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GGTTGCTTTCCGTGGTGAGGTC-3¢, and the following ampli®cation
program: 1 cycle of 94°C, 10 min; 64°C, 1 min; 72°C, 1 min; followed by
33 cycles of 94°C, 45 s; 64°C, 45 s; 72°C, 1 min; and a ®nal cycle of 94°C,
45 s; 64°C, 45 s; and 72°C, 10 min. PC1 was ampli®ed using the sense
primer 5¢-AGCAAACCCAAATCTCACCTG-3¢, the antisense primer 5¢-
TCTCCACCCCTCTTCTGTCAT-3¢, and the following ampli®cation
program: 1 cycle of 94°C, 10 min; 53°C, 45 s; 72°C, 1 min; followed by 33
cycles of 94°C, 45 s; 53°C, 45 s; 72°C, 1 min; and a ®nal cycle of 94°C,
45 s; 53°C, 45 s; and 72°C, 10 min. PC2 was ampli®ed using the sense
primer 5¢-GTGAAAATGGCTAAAGACTGG-3¢, the antisense primer 5¢-
GTTGCGTTGACCGTGATGACA-3¢, and the following ampli®cation
program: 1 cycle of 94°C, 10 min; 52°C, 30 s; 72°C, 45 s; followed by 33
cycles of 94°C, 30 s; 52°C, 30 s; 72°C, 45 s; and a ®nal cycle of 94°C, 30 s;
52°C, 30 s; and 72°C, 10 min. 7B2 was ampli®ed using the sense primer
5¢-CACCAGGCCATGAATCTT-3¢, the antisense primer 5¢-CTG-
GATCCTTATCCTCATCTG-3¢, and the following ampli®cation pro-
gram: 1 cycle of 94°C, 5 min; 53°C, 45 s; 72°C, 2 min; followed by 33
cycles of 94°C, 1 min; 53°C, 45 s; 72°C, 1 min; and a ®nal cycle of 94°C,
1 min; 53°C, 45 s; and 72°C, 10 min. Aliquots of reaction products were
run on 1.5% agarose gels and analyzed by product size compared with a
coampli®ed control template, or by cutting of the isolated fragment with
appropriate restriction enzymes, or by DNA sequencing.
Quanti®cation of PCR products To semiquantify the relative
amounts of POMC or PC1 mRNA the signal intensity of the POMC or
PC1 PCR product was compared by densitometer reading with that of a b-
actin PCR product ampli®ed from the same cDNA in a separate PCR
reaction. Ampli®cation fragments were separated on 1.5% agarose gels. The
intensity of the ethidium-bromide-stained band of a speci®c product was
densitometrically evaluated using a BioPro®l Video Densitometer, Image
Analysis and Photo Documentation System (CCD video camera/
transilluminator connected to a PC equipped with a frame grabber video
card) with BioPro®l 2-D Image Processing and Analyzing Software (FroÈbel
Labortechnik, Wasserburg, Germany). Densitometer readings of POMC-
or PC1-speci®c PCR products were normalized to the b-actin product
density in the respective sample. Subsequently, the density of POMC or
PC1 product ampli®ed from cDNA prepared from stimulated cells was
related to that of unstimulated control cells at any given time point. Unless
stated otherwise, results from three different experiments were expressed in
percentage of control as the mean 6 SEM with the density of unstimulated
controls set to 100% for each time point analyzed.
Northern hybridization Total RNA samples (15 mg per lane) were
electrophoresed on a 1% agarose formaldehyde gel, transferred to nylon
membrane (Amersham Pharmacia Biotech, Piscataway, NJ), and hybridized
with a 32P-radiolabeled human cDNA probe corresponding to human
POMC exon 3 using RapidHybe hybridization solution (Amersham).
DNA probes were radiolabeled using the random hexamer method
(Feinberg and Vogelstein, 1983) (rediprime labeling system; Amersham).
Normalization of cytokine mRNA for equal RNA loading of lanes and
northern blot transfer ef®ciency was accomplished by hybridization of
®lters with a cDNA fragment of human b-actin.
ACTH/a-MSH radioimmunoassay Cell supernatants or cell lysates
were harvested as described earlier (Chakraborty et al, 1995). Brie¯y,
aprotinin (0.01%) and phenylmethylsulfonyl ¯uoride (1 mM) were added to
cell supernatants of UV- or cytokine-treated HDMECs after stimulation.
Acetic acid (5 N) was added and media were centrifuged at 16,000g to
remove any precipitates. Supernatants were collected, the pH was adjusted
to 7.5, and the media were centrifuged again to remove any precipitates.
Supernatants were collected, freeze dried under vacuum, and stored at
±80°C. To harvest cell lysates, the medium was removed, and the cells
were washed with PBS, collected, homogenized in 5 N acetic acid using a
cell scraper, and processed as described above. The ACTH or a-MSH
contents of freeze-dried cell supernatants or lysates were analyzed using
commercially available radioimmunoassay (EuroDiagnostica, MalmoÈ,
Sweden). According to the manufacturer's protocol, the antiserum used
in the a-MSH radioimmunoassay was directed against the C-terminal part
of a-MSH recognizing a-MSH and Des-acetyl-a-MSH, with no cross-
reactivity against ACTH, b-MSH, or g-MSH. The antiserum against
ACTH was directed to the N-terminal portion of ACTH 1±39, with no
cross-reactivity against a-, b-, or g-MSH. The total protein contents of cell
lysates were determined using the Bio-Rad D/C protein assay system (Bio-
Rad Laboratories, Hercules, CA).
Statistical signi®cance Unless indicated otherwise, experiments were
performed at least three times and are presented as mean 6 SEM. The
unpaired Student's t test was used to calculate the statistical signi®cance.
RESULTS
HDMECs express POMC mRNA constitutively and upon
stimulation with IL-1b To determine if HDMECs express
POMC mRNA, RT-PCR was conducted using the ampli®cation
of a 143 bp POMC fragment that corresponds to POMC exon 2.
The ampli®cation of a 300 bp b-actin fragment served as internal
control re¯ecting the relative amount of mRNA in each sample.
HDMECs constitutively express low amounts of POMC mRNA at
1, 5, 12, and 24 h (Fig 1A). Previously, it has been demonstrated
for keratinocytes in vitro that IL-1b is capable of upregulating
POMC mRNA (Schauer et al, 1994). Thus, HDMECs were
stimulated with various concentrations of IL-1b and POMC
mRNA expression was measured 1, 5, 12, and 24 h post induction
(Fig 1A). Semiquantitative densitometric evaluation of PCR
products revealed that IL-1b in a concentration-dependent
manner upregulated POMC mRNA 1 h after stimulation.
Maximum POMC levels were observed 5 h after stimulation
with 1 ng per ml IL-1b with a subsequent decline to basal levels of
POMC mRNA expression after 24 h (Fig 1B).
POMC mRNA expression in HDMECs is upregulated upon
UVB or UVA1 irradiation UV irradiation is one of the major
stimuli for POMC mRNA and peptide expression in epidermal
cells such as melanocytes and keratinocytes (Chakraborty et al,
1995; Slominski and Pawelek, 1998; Luger et al, 1999). We tested
the possibility that UV may also have a direct impact on HDMEC
POMC production. In unirradiated control cells, the level of
POMC mRNA was similar at all time points. Irradiation of
HDMECs with UVA1 light (30 J per cm2) increased the amount of
POMC mRNA with a 2.5±4-fold induction compared with
unirradiated controls at 3 and 48 h post irradiation, respectively
(Fig 2A, B). This late inductive effect may be mediated by the
autocrine effect of UV-induced HDMEC cytokines. Likewise,
irradiation with UVB (12.5 mJ per cm2) resulted in a very similar
temporal expression pro®le compared with unstimulated control
cells with increased POMC mRNA 1±3 h after irradiation peaking
again after 24 and 48 h (Fig 2C, D). In addition, we performed
northern hybridization to exclude the unlikely possibility that
HDMEC primary cultures were contaminated with few
nonendothelial skin cells resulting in false positive RT-PCR
results. As evident from Fig 2(E), HDMEC POMC mRNA is
induced 3 h after treatment with IL-1 (1 ng per ml), UVA1 light
Figure 1. Kinetics and concentration dependence of POMC mRNA upregulation in relation to b-actin expression after stimulation with IL-
1b. Semiquantitative RT-PCR using POMC- and b-actin-speci®c primer pairs. HDMECs (2 3 106 cells) were left untreated (control) or stimulated with
0.1 ng per ml or 1 ng per ml IL-1b for the indicated periods of time. Total RNA was harvested and subjected to RT-PCR. Ampli®cation products of
POMC (143 bp) and b-actin cDNA (300 bp) were separated on agarose gels (A) and subjected to densitometric evaluation to semiquantify POMC mRNA
expression (B). Results are expressed as mean 6 SEM of three individual experiments. *p < 0.05; **p < 0.025; ***p < 0.005 vs control.
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(30 J per cm2), or UVB light (12.5 mJ per cm2). The apparent size
of the POMC transcript detected in HDMECs was about 1.1 kB.
Viability of UVB- or UVA1-irradiated HDMECs was more than
95% as demonstrated by trypan blue exclusion (data not shown).
UV irradiation increases the production of ACTH and a-
MSH In order to investigate whether UV-induced expression of
POMC mRNA is accompanied by an increased accumulation and
release of POMC peptides, HDMEC lysates were subjected to
analysis using ACTH-speci®c radioimmunoassays after increasing
amounts of UV (Fig 3). UVB- or UVA1-treated HDMECs
responded to irradiation with an enhanced intracellular level of
ACTH 12 h after stimulation compared with untreated controls,
which declined to a minimum after 24 h and was slightly elevated
again 48 h post irradiation. The induction of ACTH was also dose
dependent with doses of 20 mJ per cm2 UVB or 30 J per cm2
UVA1 being most effective.
In the supernatants of UVA1-irradiated HDMECs basal ACTH
release was increased as early as 1 h with a maximum 24 h after
irradiation with UVA1 (Fig 4). Similar data were obtained when
HDMECs were treated with UVB (data not shown). HDMEC
supernatants also contained low levels of a-MSH after 24 and 48 h
that were signi®cantly increased upon irradiation with UVA (30 J
per cm2) or UVB (12.5 mJ per cm2) (Fig 5).
HDMECs express PC1 and 7B2 In neuroendocrine cells, the
post-translational processing of the POMC prohormone by PC1
generates ACTH and b-lipotrophic hormone (b-LPH), whereas
processing by PC2 produces a-, b, and g-MSH and endorphins. As
HDMECs release ACTH as well as a-MSH, we further tested, by
semiquantitative RT-PCR using primer pairs speci®c for PC1 and
PC2, whether HDMECs express PCs necessary for POMC
precursor processing. In addition, we examined whether
HDMECs express the PC2-binding protein 7B2 that is required
for the zymogen activation of PC2. Accordingly, unstimulated cells
were found to constitutively express low levels of PC1 transcripts.
PC1 mRNA levels in HDMECs were enhanced up to 400%
compared with untreated control cells 1±5 h after stimulation with
IL-1b (1 ng per ml) or a-MSH (10±8 M, Fig 6A, B). Like the
POMC mRNA expression, the expression of PC1 mRNA is also
differentially modulated by UVA1 (Fig 7A, B) or UVB light (data
not shown). Time course studies of PC1 mRNA expression in
UVA1-irradiated HDMECs again revealed a biphasic induction
pro®le with an elevated PC1 mRNA level 1±3 h and 24±48 h post
irradiation. This suggests that UV affects the expression of PC
mRNA in a direct as well as an indirect manner. The level of PC1
mRNA in unirradiated controls was unaffected at all time points. In
addition, unstimulated and IL-1b-stimulated HDMECs (Fig 8) as
well as transformed dermal microvascular endothelial cells
Figure 2. Kinetics of POMC mRNA upregulation in relation to b-
actin expression after stimulation with UV light. HDMECs (2 3 106
cells) were stimulated with UVA1 light (30 J per cm2, A), UVB light
(12.5 mJ per cm2, C), or left untreated (control). Total RNA was harvested
after the indicated periods of time and subjected to RT-PCR (A, C).
Ampli®cation products of POMC (143 bp) and b-actin cDNA (838 bp)
were separated on agarose gels and analyzed by densitometry (B, D).
Representative data of three different experiments are shown. For northern
hybridization (E), HDMECs (2 3 106 cells) were stimulated with UVB
light (12.5 mJ per cm2), UVA1 light (30 J per cm2), IL-1b (1 ng per ml), or
left untreated (control). Total RNA was harvested after 3 h, and 15 mg per
lane were separated on a 1% formaldehyde agarose gel, blotted on nylon
membrane, and hybridized with a probe for POMC or b-actin,
respectively.
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(HMEC-1) (data not shown) express mRNA for 7B2 as detected
by RT-PCR. Both HMEC-1 and HDMECs also expressed 7B2
protein as detected by western blotting (data not shown).
DISCUSSION
The interaction between the immune system and neuropeptides
that are generated from the POMC prohormone representing a
conspicuous part of the neuroendocrine system has been receiving
increasing attention. Among the POMC peptides, numerous
studies demonstrated a unique physiologic signi®cance as immu-
nomodulator especially for a-MSH in the immune system and the
skin immune system in particular (Lipton et al, 1997; Luger et al,
1997; Scholzen et al, 1998a). Recent studies revealed that the skin is
not only the target but also the site of POMC expression. It is now
well established that normal murine or human keratinocytes,
melanocytes, Langerhans cells, and ®broblasts express POMC
mRNA and peptides such as a-MSH, ACTH, or b-endorphin in
vitro (Schauer et al, 1994; Chakraborty et al, 1995; Farooqui et al,
1995; Wintzen et al, 1996; Teofoli et al, 1997; Peters et al, 2000).
Most of these peptides have also been identi®ed by immunohis-
tochemical staining or the combination of peptide extraction,
reversed phase high performance liquid chromatography, and
radioimmunoassay in murine or human skin in vivo (Thody et al,
1983; Liu and Johansson, 1995; Slominski et al, 1995; 1999; Furkert
et al, 1997; Wakamatsu et al, 1997; Slominski and Pawelek, 1998).
In this study we demonstrate that POMC mRNA, certain
components of the POMC prohormone-processing apparatus, as
well as the POMC peptides ACTH and a-MSH are also expressed
and released by HDMECs. In addition, it is noteworthy that similar
POMC expression and regulation patterns could also be detected in
HMEC-1 (Scholzen et al, unpublished). Thus, it appears to be
unlikely that our observations on HDMEC POMC expression are
due to cell culture contamination with nonendothelial cells such as
®broblasts.
Our northern hybridization and semiquantitative RT-PCR
studies detected a low expression level of POMC mRNA in
unstimulated HDMECs that was signi®cantly enhanced upon
stimulation with IL-1 in a time- and concentration-dependent
manner. These ®ndings are in accordance with previous studies that
demonstrated only minor amounts of POMC transcripts and
peptides in unstimulated keratinocytes. Treatment of these cells
with IL-1b or UVB signi®cantly upregulated POMC mRNA
expression as well as a-MSH and ACTH release (Kock et al, 1991;
Schauer et al, 1994; Luger et al, 1999). Likewise, POMC expression
in normal skin could only be detected in skin appendages whereas a
strong expression of POMC was apparent in lesional skin affected
by diseases such as psoriasis or in cutaneous tumors, i.e., in basal cell
carcinoma or in melanoma (Slominski et al, 1993b, 1995;
Nagahama et al, 1998).
Irradiation with UVB or UVA1 in a time- and dose-dependent
manner upregulates the POMC mRNA expression and the POMC
peptide release by HDMECs. The amount of intracellular as well as
released a-MSH and ACTH after UV was comparable with
amounts previously reported for keratinocytes and melanocytes
(Schauer et al, 1994; Chakraborty et al, 1996b). Notably, the
baseline level of a-MSH detected in HDMEC supernatants
(around 10 pM = 16.6 pg per ml) was very similar to plasma a-
MSH levels detected in normal healthy volunteers (12 pM = 20 pg
per ml; Catania et al, 1998).
In a similar manner to POMC, the mRNA expression of PC 1 is
regulated by UV light. This biphasic effect of UV on POMC and
PC1 mRNA expression is re¯ected by an initial induction period
1±3 h after irradiation, followed by a decline at 6 and 16 h, and a
subsequent induction at 48 h. A comparable biphasic modulation
has been reported for TNF-a-induced keratinocyte intercellular
adhesion molecule I (ICAM-1) expression as well as for UV-
Figure 3. Kinetics of intracellular ACTH production after UV.
HDMECs were treated with 30 J per cm2 UVA1 or 10 mJ per cm2 UVB as
indicated, or left untreated (control), and cells were harvested after 12, 24,
and 48 h. ACTH was determined by radioimmunoassay in relation to the
total protein contents of cell lysates as determined by BCA assay. Values are
given in pmol per g total protein 6 SEM. *p < 0.05; **p < 0.025;
***p < 0.005 vs control at each given time point.
Figure 4. ACTH release by UV-irradiated HDMECs. Cells were
irradiated with 30 J per cm2 UVA1 or left untreated (control) and
supernatants were collected after the indicated time periods. ACTH was
determined using speci®c radioimmunoassay or enzyme immunoassays.
Values are given in pM 6 SEM. *p < 0.05; **p < 0.01; ***p < 0.001 vs
control.
Figure 5. a-MSH release by UV-irradiated HDMECs. Cells were
irradiated with 30 J per cm2 UVA1, with UVB (12.5 mJ per cm2), or left
untreated (control), and supernatants were collected after the indicated time
periods. a-MSH was determined using speci®c radioimmunoassay or
enzyme immunoassays. Values are given in pM 6 SEM. *p < 0.05;
**p < 0.01; ***p < 0.001 vs control.
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induced keratinocyte TNF-receptor I expression, melanocyte
ICAM-1 expression, and for endothelial cell cytokine production
(Kirnbauer et al, 1992; Trefzer et al, 1993; Scholzen et al, 1998b).
The transcriptional upregulation of POMC and PC1 mRNA by
UV light as soon as 1 h post irradiation seems to favor a direct effect
of UV on HDMECs indicating that the induction of both genes
may represent a part of the immediate-early gene response of
HDMECs to UV light.
Although UV directly as well as indirectly affects the function of
endothelial cells in vitro, there is some concern about the in vivo
relevance of these ®ndings as epidermal cells are regarded as the
primary target for UV irradiation. There is recent evidence,
however, that UVB in the range between 0.5 and 3 minimal
erythema doses signi®cantly damages basal keratinocytes as
demonstrated by thymidine dimer formation (Young et al, 1997).
In addition, based on transmission data of ex vivo irradiated human
epidermis, about 40% of UVA seems to be able to penetrate to the
dermis and to reach cutaneous vessels (Everett et al, 1966). Thus, it
appears to be likely that a signi®cant amount of UVB and in
particular of long-wavelength UVA reaches the upper dermis and
directly alters the function of vessel cells in the dermal papillae in
vivo.
In accordance with previous observations our data demonstrate
that only a limited number of stimuli including UV light are
capable of inducing POMC expression in epidermal as well as
dermal cells. Among various cytokines, so far only IL-1 and TNF-a
have been proven to induce POMC expression in human
keratinocytes and some epidermoid carcinoma cell lines or
®broblasts (Schauer et al, 1994; Wintzen et al, 1996; Teofoli et al,
1997). In extension of these data, our ®ndings indicate that IL-1 is
also capable of increasing the expression level of PC1 mRNA in a
time- and concentration-dependent manner. IL-1 has been
reported to be induced in HDMECs and other skin cells such as
keratinocytes upon irradiation with UVB and UVA1 light1 (Luger
et al, 1995; Scholzen et al, 1998b). Thus, it can be speculated that
the second induction of POMC and of PC1 mRNA observed in
HDMECs after 24 h might be an autocrine or paracrine effect
mediated by UV-induced IL-1. It is noteworthy that induction of
keratinocyte POMC expression by UVB light in vitro could be
blocked by preincubation of keratinocytes with the IL-1 receptor
antagonist (Brzoska et al, unpublished observation). Therefore, it
seems to be conceivable that, in addition to a direct POMC
induction by UV light and an autocrine/paracrine induction of
POMC via endothelial-cell-derived IL-1, keratinocyte-derived IL-
1 may also account for POMC production in endothelial cells in
vivo.
Understanding the regulation of POMC expression in skin and
other tissues in relation to PC expression is important, as the
expression level of these proteolytic enzymes may affect the POMC
prohormone processing. In the pituitary, POMC expression and
post-translational POMC prohormone processing occur in a cell-
and tissue-speci®c manner. In corticotrophic cells of the anterior
pituitary, where ACTH and b-LPH are the predominant POMC
products, PC1 is highly expressed, whereas only very low levels of
PC2 are found. In contrast, intermediate lobe melanotrophic cells
express both PC1 and PC2 at high levels with PC2 being more
abundant. In this tissue, ACTH and b-LPH are also further
processed to a-MSH, corticotrophin-like intermediate lobe
peptide, g-LPH, and b-endorphins (Zhou et al, 1993; Castro and
Morrison, 1997). A similar system for POMC processing in
different skin compartments equivalent to that in melanotrophic
and corticotrophic cells of the pituitary has been proposed earlier
(Slominski et al, 1993a). Recently, examination of human
melanocytes demonstrated that the entire system for POMC
processing is present within the melanosome (Peters et al, 2000).
Figure 6. Kinetics of PC1 mRNA expression. PC1 mRNA was compared to b-actin expression after stimulation with IL-1b and a-MSH. HDMECs
(2 3 106 cells) were left untreated (control) or stimulated with IL-1b (1 ng per ml) or a-MSH (10±8 M), respectively, for the indicated periods of time. Total
RNA was subjected to RT-PCR and ampli®cation products of PC1 (674 bp) and b-actin cDNA (300 bp) were separated on agarose gels (A), and evaluated
densitometrically to semiquantify PC1 mRNA expression (B). Results are expressed as mean 6 SEM of three individual experiments. *p < 0.05;
**p < 0.025; ***p < 0.005 vs control.
Figure 7. Kinetics of PC1 mRNA upregulation in comparison to b-
actin expression after irradiation with UVA1 light. HDMECs
(2 3 106 cells) were left untreated (control) or stimulated with 30 J per
cm2 UVA1 for the indicated periods of time. After RT-PCR of total
RNA, ampli®cation products of PC1 (674 bp) and b-actin cDNA (834 bp)
were separated on agarose gels (A) and subjected to densitometric
evaluation to semiquantify PC1 mRNA expression (B). Representative
data of two different experiments are shown.
1Scholzen T, Hartmeyer M, Fastrich M, Becher E, Brzoska T, Schwarz
T, Luger TA: Chemokine and cytokine expression by human dermal
microvascular endothelial cells is differentially modulated upon irradiation
with UVA1-light. J Invest Dermatol 108:650, 1997 (abstr.)
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Little is known about the cell-speci®c expression and molecular
regulation of POMC processing proteolytic enzymes in other skin
cells. Here we have reported that PC1 mRNA is expressed in
HDMECs and regulated by UV, IL-1, and a-MSH itself. These
observations seem to be of particular importance as to date the
expression of the POMC prohormone processing enzymes PC1
and PC2 seemed to be exclusively restricted to cells and tissues of
endocrine and neuroendocrine origin (Castro et al, 1997). So far,
the exact mechanism of PC regulation in HDMECs by MSH or
IL-1 is unknown. Stimulation of protein kinase C and cAMP was
demonstrated to regulate PC mRNA expression (Mania-Farnell
and Davis, 1996). Thus, one could speculate that HDMEC a-MSH
treatment resulting in MC-1R activation and subsequently
increased intracellular cAMP (Scholzen et al, unpublished) in an
autocrine manner may elevate PC1 mRNA levels in HDMECs via
cAMP-dependent pathways. IL-1, which is known to activate
protein kinase C, may upregulate PC1 in HDMECs involving
protein kinase C.
In addition to PC1, HDMECs were also found to express
mRNA of the PC2 binding protein 7B2. This is of particular
importance as 7B2 was demonstrated to be a critical cofactor for the
autocatalytic conversion of the zymogen proPC2 that generates the
full biologically active enzyme PC2 (Benjannet et al, 1995, 1998).
Interestingly, according to our data HDMECs do not express PC2
mRNA that is necessary to generate a-MSH in melanotrophic
pituitary cells. PC2-speci®c PCR products were detected, how-
ever, when cDNA prepared from pituitary tissue was subjected to
PCR ampli®cation, which served as a positive control (data not
shown). Nevertheless, a-MSH could be detected in unstimulated
HDMECs by immunohistochemistry (data not shown) and we
have demonstrated the presence of a-MSH in supernatants of
unstimulated and stimulated HDMECs. This might in part be
explained by the heterogenicity of PC2 mRNA splicing resulting
in a much longer PC2 transcript in the skin compared with other
tissues including pituitary (Seidah et al, 1999). Thus, we cannot
exclude that the PC2-speci®c primers used in our studies were
unable to detect this longer transcript, as these primers were
deducted from a human pituitary PC2 mRNA sequence.
Nevertheless, it is also possible that a different, not yet identi®ed,
endopeptidase accounts for POMC prohormone processing in
order to generate a-MSH in certain skin cells. For example, the
expression of the zinc metalloprotease neutral endopeptidase (NEP;
EC 3.4.24.11; also known as CD10 or enkephalinase) has been
demonstrated in human cells including HDMECs (Olerud et al,
1999). NEP has been shown to process POMC to a-MSH and
other peptides in invertebrates and higher vertebrates including
man (Smith et al, 1992; Salzet et al, 1997).
Taken together, our data indicate that UV light is capable of
simultaneously upregulating the expression not only of POMC in
HDMECs but also of PC1, one of the major proteolytic enzymes
required to process the POMC prohormone presumably involving
IL-1 as a key mediator. This could implicate that under certain
experimental conditions the expression of neuropeptide convertases
and their substrates might be synergistically regulated by similar
mediators on the transcriptional or translational level.
In a recent study we have demonstrated that a-MSH is capable
of signi®cantly impairing lipopolysaccharide (LPS)- or TNF-a-
induced MC-1R-mediated endothelial cell VCAM-1 and E-
Selectin mRNA and protein expression in vitro. This was mediated
by inhibition of TNF-a- or LPS-induced NF-kB activation and
nuclear translocation (Kalden et al, 1999). Moreover, in a mouse
model for the local Shwartzman reaction systemic a-MSH
treatment signi®cantly reduced the sustained expression of E-
selectin and VCAM-1 as well as the development of lesions that
normally characterizes this LPS-induced leukocytoclastic vasculitis
(Sunderkotter et al, 1999). Thus, endothelial-cell-produced a-
MSH may locally serve to dampen an in¯ammatory response. The
simultaneous expression of POMC peptides and their correspond-
ing receptors may be important not only for the autocrine
regulation of dermal endothelial cell functions. One could speculate
that a-MSH and ACTH, if released by HDMECs into the vascular
lumen in vivo, might locally or systemically achieve concentrations
suf®ciently high to alter functions of circulating or adherent
leukocytes. Due to their multiple anti-in¯ammatory and immu-
nosuppressive effects endothelial-cell-derived POMC peptides may
signi®cantly contribute to UV-mediated in¯ammation and im-
munomodulation.
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